Clinical Trial Update: Impact of Oral Versatile Antioxidants on Glaucoma Progression [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of oral versatile antioxidants on glaucoma progression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Oral Versatile Antioxidants

Snippet

Sponsor: Bagcilar Training and Research Hospital | Conditions: Glaucoma | Phase 3 | Status: COMPLETED